BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Borza DB. Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy. Front Immunol 2016;7:157. [PMID: 27199983 DOI: 10.3389/fimmu.2016.00157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Łukawska E, Polcyn-adamczak M, Niemir ZI. The role of the alternative pathway of complement activation in glomerular diseases. Clin Exp Med 2018;18:297-318. [DOI: 10.1007/s10238-018-0491-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
2 Haddad G, Lorenzen JM, Ma H, de Haan N, Seeger H, Zaghrini C, Brandt S, Kölling M, Wegmann U, Kiss B, Pál G, Gál P, Wüthrich RP, Wuhrer M, Beck LH, Salant DJ, Lambeau G, Kistler AD. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. J Clin Invest 2021;131:140453. [PMID: 33351779 DOI: 10.1172/JCI140453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
3 Mizuno M, Suzuki Y, Ito Y. Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology. Clin Exp Nephrol 2018;22:3-14. [DOI: 10.1007/s10157-017-1405-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
4 Koopman JJE, van Essen MF, Rennke HG, de Vries APJ, van Kooten C. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys. Front Immunol 2020;11:599974. [PMID: 33643288 DOI: 10.3389/fimmu.2020.599974] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Feng Z, Liu W, Jiang HX, Dai H, Gao C, Dong Z, Gao Y, Liu F, Zhang Z, Zhao Q, Zhang L, Liu B. How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy? Front Pharmacol 2020;11:994. [PMID: 32719601 DOI: 10.3389/fphar.2020.00994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Luo W, Olaru F, Miner JH, Beck LH Jr, van der Vlag J, Thurman JM, Borza DB. Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy. Front Immunol 2018;9:1433. [PMID: 29988342 DOI: 10.3389/fimmu.2018.01433] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
7 Wang S, Lu Y, Hong Q, Geng X, Wang X, Zheng W, Song C, Liu C, Fan M, Xi Y, Guo M, Wu D. Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy. Biomed Res Int 2017;2017:7843584. [PMID: 28337458 DOI: 10.1155/2017/7843584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Safar-boueri L, Piya A, Beck LH, Ayalon R. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol 2021;36:19-30. [DOI: 10.1007/s00467-019-04425-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Aleš Rigler A, Večerić-Haler Ž, Arnol M, Perše M, Boštjančič E, Pleško J, Simčič S, Kojc N. Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation. J Int Med Res 2020;48:300060520980530. [PMID: 33372813 DOI: 10.1177/0300060520980530] [Reference Citation Analysis]
10 Zhang Y, Huang Y, Huang B, Chen X, Zhou B, Zou P, Wang L, Liu X, Sheng H, Xie M, Zeljezic D. Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy. BioMed Research International 2022;2022:1-9. [DOI: 10.1155/2022/9127520] [Reference Citation Analysis]
11 Iranzad R, Motavalli R, Ghassabi A, Pourakbari R, Etemadi J, Yousefi M. Roles of microRNAs in renal disorders related to primary podocyte dysfunction. Life Sci 2021;277:119463. [PMID: 33862110 DOI: 10.1016/j.lfs.2021.119463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Dickinson BL. Unraveling the immunopathogenesis of glomerular disease. Clin Immunol 2016;169:89-97. [PMID: 27373970 DOI: 10.1016/j.clim.2016.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
13 Borza DB. Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Matrix Biol. 2017;57-58:299-310. [PMID: 27609404 DOI: 10.1016/j.matbio.2016.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
14 Oto OA, Demir E, Mirioglu S, Dirim AB, Ozluk Y, Cebeci E, Basturk T, Ucar AR, Soltanova L, Nuriyev K, Kilicaslan I, Yazici H, Caliskan Y. Clinical significance of glomerular C3 deposition in primary membranous nephropathy. J Nephrol 2021;34:581-7. [PMID: 33387338 DOI: 10.1007/s40620-020-00915-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 van Essen MF, Ruben JM, de Vries APJ, van Kooten C; COMBAT consortium. Role of properdin in complement-mediated kidney diseases. Nephrol Dial Transplant 2019;34:742-50. [PMID: 30053164 DOI: 10.1093/ndt/gfy233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Eldewi DM, Alhabibi AM, El Sayed HME, Mahmoud SAK, El Sadek SM, Gouda RM, Hassan MAEM, Ibrahim AH, Abd El Haliem NF. Expression levels of complement regulatory proteins (CD35, CD55 and CD59) on peripheral blood cells of patients with chronic kidney disease. Int J Gen Med 2019;12:343-51. [PMID: 31571973 DOI: 10.2147/IJGM.S216989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Li P, Zhong X, Zhang L, Yu Y, Niu J. Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy. Nephrology 2021;26:262-9. [DOI: 10.1111/nep.13833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Caza TN, Al-Rabadi LF, Beck LH Jr. How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. Front Immunol 2021;12:800242. [PMID: 34899763 DOI: 10.3389/fimmu.2021.800242] [Reference Citation Analysis]
19 Maslinska M, Dmowska-chalaba J, Jakubaszek M. The Role of IgG4 in Autoimmunity and Rheumatic Diseases. Front Immunol 2022;12:787422. [DOI: 10.3389/fimmu.2021.787422] [Reference Citation Analysis]
20 Koneczny I. A New Classification System for IgG4 Autoantibodies. Front Immunol 2018;9:97. [PMID: 29483905 DOI: 10.3389/fimmu.2018.00097] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
21 Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int 2017;91:566-74. [PMID: 28065518 DOI: 10.1016/j.kint.2016.09.048] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 14.6] [Reference Citation Analysis]
22 Li X, Wang Y. Membranous nephropathy with Neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders 2017;15:49-51. [DOI: 10.1016/j.msard.2017.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dong Z, Dai H, Gao Y, Feng Z, Liu W, Liu F, Zhang Z, Ma F, Xie X, Zhu Z, Liu W, Liu B. Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes. Exp Ther Med 2021;22:737. [PMID: 34055054 DOI: 10.3892/etm.2021.10169] [Reference Citation Analysis]
24 Jiang HX, Feng Z, Zhu ZB, Xia CH, Zhang W, Guo J, Liu BL, Wang Y, Liu YN, Liu WJ. Advances of the experimental models of idiopathic membranous nephropathy (Review). Mol Med Rep 2020;21:1993-2005. [PMID: 32186751 DOI: 10.3892/mmr.2020.11014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Filippone EJ, Farber JL. Membranous nephropathy in the kidney allograft. Clin Transplant 2016;30:1394-402. [DOI: 10.1111/ctr.12847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]